Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00462332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06073821. IPD Sharing: YES. Countries: 21. Publications: 0.
Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00290810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003659. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Prev
ClinicalTrials.gov study NCT01419795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00193466. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00940342. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00005829. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT04694560. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01980875. IPD Sharing: YES. Countries: 8. Publications: 0.
Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01444716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00230282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax
ClinicalTrials.gov study NCT04016805. IPD Sharing: YES. Countries: 1. Publications: 0.
Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02100423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT06654206. IPD Sharing: YES. Countries: 0. Publications: 2.
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01199575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Obinutuzumab in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02225275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00303966. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01563055. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion
ClinicalTrials.gov study NCT02044822. IPD Sharing: YES. Countries: 14. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.